A two step model aimed at delivering antisense oligonucleotides in targeted cells
- 26 April 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 293 (1), 18-22
- https://doi.org/10.1016/s0006-291x(02)00177-8
Abstract
No abstract availableKeywords
Funding Information
- Centre National de la Recherche Scientifique
- Magyar Tudományos Akadémia (AKP 98-99 2,4)
This publication has 8 references indexed in Scilit:
- Antisense inhibition of P-glycoprotein expression using peptide–oligonucleotide conjugatesBiochemical Pharmacology, 2000
- Delivery of Antisense Oligonucleotides and Plasmid DNA with Various Carrier AgentsAntisense and Nucleic Acid Drug Development, 1999
- Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell cultureBiochemical Pharmacology, 1999
- Liposome-Induced Conformational Changes of an Epitopic Peptide and its Palmitoylated Derivative of Influenza Virus HemagglutininBiochemical and Biophysical Research Communications, 1998
- A new peptide vector for efficient delivery of oligonucleotides into mammalian cellsNucleic Acids Research, 1997
- Synthesis and Antiviral Activity of Peptide-Oligonucleotide Conjugates Prepared by Using N.alpha.-(Bromoacetyl)peptidesBioconjugate Chemistry, 1995
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences, 1995
- Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.Proceedings of the National Academy of Sciences, 1987